Joint association of carrying HLA-B*13:01 gene and human herpesvirus-6 with occupational trichloroethylene hypersensitivity syndrome

[1]  T. Shen,et al.  The immune response in trichloroethylene hypersensitivity syndrome: A review , 2017, Toxicology and industrial health.

[2]  H. Wang,et al.  A multiplex allele‐specific real‐time polymerase chain reaction assay for HLA‐B*13:01 genotyping in four Chinese populations , 2016, HLA.

[3]  S. Mallal,et al.  Evolving models of the immunopathogenesis of T cell-mediated drug allergy: The role of host, pathogens, and drug response. , 2015, The Journal of allergy and clinical immunology.

[4]  Huanming Yang,et al.  Performance of genetic risk factors in prediction of trichloroethylene induced hypersensitivity syndrome , 2015, Scientific Reports.

[5]  Ersoy Öz,et al.  Detailed polymorphism study on cytomegalovirus DNA polymerase gene to reveal the most suitable genomic targets for quantitative Real-time PCR. , 2015, Bosnian journal of basic medical sciences.

[6]  Imir G. Metushi,et al.  T cell-mediated hypersensitivity reactions to drugs. , 2015, Annual review of medicine.

[7]  T. Shiohara,et al.  The dynamics of herpesvirus reactivations during and after severe drug eruptions: their relation to the clinical phenotype and therapeutic outcome , 2014, Allergy.

[8]  M. Tohyama,et al.  Occupational trichloroethylene hypersensitivity syndrome: human herpesvirus 6 reactivation and rash phenotypes. , 2013, Journal of dermatological science.

[9]  J. Fishman.  Overview: Cytomegalovirus and the Herpesviruses in Transplantation , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[10]  R. Razonable,et al.  Human herpesvirus‐6 infections in kidney, liver, lung, and heart transplantation: review , 2012, Transplant international : official journal of the European Society for Organ Transplantation.

[11]  M. De Paschale,et al.  Positive predictive value of anti-HCMV IgM as an index of primary infection. , 2010, Journal of virological methods.

[12]  M. Tohyama,et al.  Occupational Trichloroethylene Hypersensitivity Syndrome with Human Herpesvirus-6 and Cytomegalovirus Reactivation , 2010, Dermatology.

[13]  Hai-yan Huang,et al.  Severe hypersensitivity dermatitis and liver dysfunction induced by occupational exposure to trichloroethylene. , 2009, Industrial health.

[14]  Li Zu-guo.  Study on the clinical skin pathology of medicamentose-like dermatitis induced by trichloroethylene , 2008 .

[15]  M. Tohyama,et al.  Association of human herpesvirus 6 reactivation with the flaring and severity of drug‐induced hypersensitivity syndrome , 2007, The British journal of dermatology.

[16]  S. Leng,et al.  HLA-B*1301 as a Biomarker for Genetic Susceptibility to Hypersensitivity Dermatitis Induced by Trichloroethylene among Workers in China , 2007, Environmental health perspectives.

[17]  N. Hisanaga,et al.  Occupational trichloroethylene exposure as a cause of idiosyncratic generalized skin disorders and accompanying hepatitis similar to drug hypersensitivities , 2007, International archives of occupational and environmental health.

[18]  T. Yoshikawa,et al.  Human Herpesvirus 6 Reactivation in Trichloroethylene‐exposed Workers Suffering from Generalized Skin Disorders Accompanied by Hepatic Dysfunction , 2006, Journal of occupational health.

[19]  K. Cao,et al.  Analysis of the frequencies of HLA-A, B, and C alleles and haplotypes in the five major ethnic groups of the United States reveals high levels of diversity in these loci and contrasting distribution patterns in these populations. , 2001, Human immunology.

[20]  D Middleton,et al.  Analysis of the distribution of HLA-B alleles in populations from five continents. , 2000, Human immunology.

[21]  H. Inoko,et al.  Allele frequencies and haplotypic associations defined by allelic DNA typing at HLA class I and class II loci in the Japanese population. , 2000, Tissue antigens.

[22]  H. Cubie,et al.  Human herpesvirus‐6 DNA in the saliva of paediatric oncology patients and controls , 1995, Journal of medical virology.